BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25825402)

  • 1. Cardiology patient page. Statin intolerance.
    Fitchett DH; Hegele RA; Verma S
    Circulation; 2015 Mar; 131(13):e389-91. PubMed ID: 25825402
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing statins: the real issues.
    Hamilton-Craig IR
    Med J Aust; 2014 May; 200(8):440-1. PubMed ID: 24794593
    [No Abstract]   [Full Text] [Related]  

  • 3. [How do you manage muscle pain?"].
    Klein F
    MMW Fortschr Med; 2016 Feb; 158(3):19. PubMed ID: 27119671
    [No Abstract]   [Full Text] [Related]  

  • 4. Is there a need for dietary measures to further reduce LDL cholesterol in patients with type II diabetes mellitus on statin therapy?
    Winters SM; Visser H; Steerneman AH; Thomas G; Bots ML; van der Heijden GJ
    Prim Care Diabetes; 2008 Feb; 2(1):51-4. PubMed ID: 18684421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 6. Insights Into Statin Intolerance.
    Kopecky S; Baum S; Foody JM; Koren M; McKenney J; Sperling L; Wong ND;
    Clin Cardiol; 2015 Sep; 38(9):520-6. PubMed ID: 26337173
    [No Abstract]   [Full Text] [Related]  

  • 7. Stricter cholesterol guidelines broaden indications for the 'statin' drugs.
    Capriotti T
    Medsurg Nurs; 2003 Feb; 12(1):51-7. PubMed ID: 12619600
    [No Abstract]   [Full Text] [Related]  

  • 8. Achieving adherence to lipid-lowering regimens.
    Brown WV; Jacobson TA; Braun LT
    J Clin Lipidol; 2013; 7(1):4-13. PubMed ID: 23351577
    [No Abstract]   [Full Text] [Related]  

  • 9. Statins and risk of new-onset diabetes mellitus.
    Shah RV; Goldfine AB
    Circulation; 2012 Oct; 126(18):e282-4. PubMed ID: 23109518
    [No Abstract]   [Full Text] [Related]  

  • 10. [2016 European Society of Cardiology guidelines for the management of dyslipidemias].
    Ferrières J
    Presse Med; 2017; 46(7-8 Pt 1):688-696. PubMed ID: 28502376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
    Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH
    J Am Coll Cardiol; 2007 Jul; 50(5):409-18. PubMed ID: 17662392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myalgia and statins: Separating the true from the false].
    Blacher J; Bruckert E; Farnier M; Ferrières J; Henry P; Krempf M; Mourad JJ
    Presse Med; 2019 Oct; 48(10):1059-1064. PubMed ID: 31473026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a Paradigm Shift in Cholesterol Treatment. A Re-examination of the Cholesterol Issue in Japan.
    Hamazaki T; Okuyama H; Ogushi Y; Hama R
    Ann Nutr Metab; 2015; 66 Suppl 4():1-116. PubMed ID: 25925499
    [No Abstract]   [Full Text] [Related]  

  • 14. Means and ends of statins and low-density lipoprotein cholesterol lowering.
    LaRosa JC
    J Am Coll Cardiol; 2007 Jul; 50(5):419-20. PubMed ID: 17662393
    [No Abstract]   [Full Text] [Related]  

  • 15. Statin intolerance - a question of definition.
    Algharably EA; Filler I; Rosenfeld S; Grabowski K; Kreutz R
    Expert Opin Drug Saf; 2017 Jan; 16(1):55-63. PubMed ID: 27645111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statin Intolerance.
    Brown AS; Watson KE
    Rev Cardiovasc Med; 2018; 19(S1):S9-S19. PubMed ID: 30207553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein reduction and cancer: not definitive but provocative.
    DeMaria AN; Ben-Yehuda O
    J Am Coll Cardiol; 2007 Jul; 50(5):421-2. PubMed ID: 17662394
    [No Abstract]   [Full Text] [Related]  

  • 18. Growing body of evidence shows benefits of aggressive lipid management in high-risk patients.
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():3, 5. PubMed ID: 12608151
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
    Nishimura R; Sone H; Nakagami T; Tajima N
    Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of xanthine oxidase to prevent statin-induced myalgia and rhabdomiolysis.
    Alis R; Sanchis-Gomar F; Risso-Ballester J; Perez-Quilis C; Cortell-Ballester J; Romagnoli M; Blesa JR; Emanuele E
    Atherosclerosis; 2015 Mar; 239(1):38-42. PubMed ID: 25568951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.